Spots Global Cancer Trial Database for Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
Official Title: A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate
Study ID: NCT01459757
Conditions
Interventions
Study Description
Brief Summary: Retrospective correlation of clinical outcomes data with mutational status in GIST subjects treated with sunitinib.
Detailed Description: This is a non-interventional trial. No active patients will participate in this study. Only data generated from the A6181036 study will be utilized for correlational purposes. The A6181036 study data in addition to mutational status data previously analyzed but not collected as part of the A6181036 study in the same patient population
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope, Duarte, California, United States
Washington Hospital Center, Washington, District of Columbia, United States
Davis Cancer Pavilion and Shands Medical Plaza, Gainesville, Florida, United States
Shands Cancer Hospital at the University of Florida, Gainesville, Florida, United States
Shands Hospital at the University of Florida, Gainesville, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Masonic Cancer Center - Clinical Trials Office, Minneapolis, Minnesota, United States
Oregon Health and Science University, Portland, Oregon, United States
Seattle Cancer Care Alliance, Seattle, Washington, United States
University of Washington, Seattle, Washington, United States
Prince of Wales Hospital, Oncology Day Center, Randwick, New South Wales, Australia
Ashford Cancer Centre Research, Kurralta Park, South Australia, Australia
Peter MacCallum Cancer Institute, Department of Medical Oncology, East Melbourne, Victoria, Australia
UZ Leuven, Leuven, , Belgium
Hopital Notre-dame du Centre Hospitalier Universitaire de Montreal, Montreal, Quebec, Canada
Herlev Hospital, Herlev, , Denmark
Helsingin yliopistollinen keskussairaala/Syopatautien klinikka, Helsinki, , Finland
Institut Bergonie, Bordeaux Cedex, , France
Centre L� B�rd, Lyon Cedex, , France
CHU La Timone, Service d'Oncologie Medicale, Marseille, , France
HELIOS Klinikum Berlin-Buch, Klinik fuer Interdisziplinaere Onkologie, Berlin, , Germany
Schwerpunktpraxis fuer ambulante Tumortherapie, Duesseldorf, , Germany
Klinikum der Universitaet zu Koeln, Koeln, , Germany
Tata Memorial Centre, Mumbai, Maharashtra, India
Seoul National University Hospital/Department of Internal Medicine, Seoul, , Korea, Republic of
Asan Medical Center, Department of Internal Medicine, Seoul, , Korea, Republic of
Leids Universitair Medisch Centrum/ Klinische Oncologie, Leiden, , Netherlands
Klinika Nowotworow Tkanek Miekkich i Kosci, Warszawa, , Poland
Narodny Onkologicky ustav, Bratislava, , Slovakia
Hospital de la Santa Creu i Sant Pau, Barcelona, , Spain
Hospital Universitario Virgen Macarena, Sevilla, , Spain
Centre Hospitalier Universitaire Vaudois, Lausanne, , Switzerland
Sarcoma Unit, London, , United Kingdom
Christie Hospital NHS Trust, Manchester, , United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
